Search

everythinglearnresearchcommunity

for

Search:↓

Adalimumab is the most effective treatment for severe hidradenitis suppurativa, but more research is needed to improve treatment options.

The study found key factors in the cause of hidradenitis suppurativa, its link to other diseases, and identified existing drugs that could potentially treat it.

A woman's small, unnoticed adrenal mass turned out to be a rare non-Hodgkin's lymphoma, treated successfully with surgery and therapy.

Most pediatric cancer patients at Muhimbili National Hospital in Tanzania experienced side effects from chemotherapy, with nausea, hair loss, and low white blood cell count being the most common.

New treatments and management strategies for skin conditions like melanoma and Spitz naevi were discussed at the dermatologists' meeting.

Old treatments for other skin conditions showed promise for hair regrowth in mice with a hair loss condition.

A 69-year-old smoker was wrongly diagnosed with lung cancer but actually had a rare lymphatic system disorder.

Adding TERT and BMI1 to certain skin cells can improve their ability to create hair follicles in mice.

An addax had skin cancer that spread to lymph nodes and was euthanized.

The document concludes that treatment for cutaneous T-cell lymphoma should be customized to each patient's disease stage, balancing benefits and side effects, with no cure but many patients living long lives.

The growth of the Epstein-Barr virus in the patient's cells was linked to the worsening of her lymphoma.

Some patients with a type of skin lymphoma can experience a rare, non-scarring hair loss that looks like another hair loss condition but has distinct features.

Vesiculobullous lesions should be considered part of canine cutaneous epitheliotropic T-cell lymphoma.

Deleting the MAD2L1 gene is tolerated in certain mouse cancer models.

Deleting the MAD2L1 gene in mice led to rapid tumor growth despite chromosomal instability.

Early diagnosis and aggressive treatment are crucial for better outcomes in lymphomatoid granulomatosis.

The COVID-19 pandemic led to fewer patient visits, more visits by older adults, an increase in cutaneous T-cell lymphoma cases, and a rise in noncosmetic procedures at a dermatology clinic.

A patient with Sézary syndrome showed improvement after treatment and the study suggested follicular mucinosis might indicate future lymphoma risk.

Alopecia areata can be an early sign of Hodgkin’s lymphoma and may improve with lymphoma treatment.

Patients with chronic graft-versus-host disease often have skin problems like vitiligo and alopecia areata.

JAK inhibitors help with skin conditions but need more research on dosing and safety.

Methotrexate is a key, cost-effective drug for skin conditions, but requires careful monitoring for side effects.

Eyebrow loss has many causes and requires accurate diagnosis for proper treatment.

Hair loss can be caused by stress, infections, drugs, and various diseases, with treatment depending on accurate diagnosis.

A patient with a severe type of hair loss experienced partial hair regrowth after treatment with a specific light therapy and a medication called interferon α2a.

Mindfulness reduces anxiety and depression in skin disease patients; dermatologists and psychiatrists often lack confidence in treating psychodermatological conditions.

Treating skin conditions with both psychological and dermatological care improves patient outcomes and can save costs.

The issue concluded that various skin conditions have different effective treatments and factors influencing them.

The document concludes that there have been significant improvements in diagnosing and treating skin diseases, including melanoma, with new techniques and therapies.

Newborn screening and gene therapy are expected to improve outcomes for Omenn syndrome patients.